Estimated direct costs of non‐small cell lung cancer by stage at diagnosis and disease management phase: A whole‐disease model

Estimated direct costs of non‐small cell lung cancer by stage at diagnosis and disease management phase: A whole‐disease model

Background Non‐small cell lung cancer (NSCLC) is the first cause of cancer‐related death among men and the second among women worldwide. It also poses an economic threat to the sustainability of healthcare services. This study estimated the direct costs of care for patients with NSCLC by stage at di...

Full description

Bibliographic Details
Main Authors: Alessandra Buja, Michele Rivera, Anna De Polo, Eugenio di Brino, Marco Marchetti, Manuela Scioni, Giulia Pasello, Alberto Bortolami, Vincenzo Rebba, Marco Schiavon, Fiorella Calabrese, Giovanni Mandoliti, Vincenzo Baldo, PierFranco Conte
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Thoracic Cancer
Subjects:
Cost of illness
economic models
lung cancer burden
practice guidelines
Online Access:https://doi.org/10.1111/1759-7714.13616

Internet

https://doi.org/10.1111/1759-7714.13616

Similar Items